Evotec AG O.N. (EVTG)

Currency in EUR
5.972
-0.124(-2.03%)
Closed·
EVTG Scorecard
Full Analysis
Analysts do not anticipate the company will be profitable this year
EVTG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.9466.080
52 wk Range
5.06010.620
Key Statistics
Bid/Ask
5.972 / 5.978
Prev. Close
5.972
Open
6.038
Day's Range
5.946-6.08
52 wk Range
5.06-10.62
Volume
1.51M
Average Volume (3m)
1.23M
1-Year Change
-3.52%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EVTG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
9.429
Upside
+57.88%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has fared poorly over the last month

Evotec AG O.N. News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Evotec AG O.N. Company Profile

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just – Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic disease, and rare diseases; central nervous system (CNS) and cardiometabolic diseases; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. It has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB. The company serves pharma and biotechnology companies, academic institutions, patient advocacy groups, and venture capital. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Employees
4759
Market
Germany

Compare EVTG to Peers and Sector

Metrics to compare
EVTG
Peers
Sector
Relationship
P/E Ratio
−6.8x12.4x−0.5x
PEG Ratio
−0.770.240.00
Price/Book
1.3x2.8x2.6x
Price / LTM Sales
1.4x5.2x3.3x
Upside (Analyst Target)
62.4%364.9%38.7%
Fair Value Upside
Unlock29.0%5.0%Unlock

Analyst Ratings

6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 9.429
(+57.88% Upside)

Earnings

Latest Release
Aug 13, 2025
EPS / Forecast
-0.245 / -0.115
Revenue / Forecast
171.20M / 201.15M
EPS Revisions
Last 90 days

EVTG Income Statement

People Also Watch

650.60
ASML
+0.60%
26.45
DAST
-1.27%
68.90
TEPRF
-4.65%
11.930
SDFGn
+0.25%
26.580
UTDI
+0.30%

FAQ

What Stock Exchange Does Evotec AG Trade On?

Evotec AG is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Evotec AG?

The stock symbol for Evotec AG is "EVTG."

What Is the Evotec AG Market Cap?

As of today, Evotec AG market cap is 1.06B.

What Is Evotec AG's Earnings Per Share (TTM)?

The Evotec AG EPS (TTM) is -0.88.

When Is the Next Evotec AG Earnings Date?

Evotec AG will release its next earnings report on 04 Nov 2025.

From a Technical Analysis Perspective, Is EVTG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Evotec AG Stock Split?

Evotec AG has split 2 times.

How Many Employees Does Evotec AG Have?

Evotec AG has 4759 employees.

What is the current trading status of Evotec AG (EVTG)?

As of 27 Aug 2025, Evotec AG (EVTG) is trading at a price of 5.97, with a previous close of 5.97. The stock has fluctuated within a day range of 5.95 to 6.08, while its 52-week range spans from 5.06 to 10.62.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.